Skip to content

Effectiveness of an Electronic Training Program for Orienting and Interpreting [18F]Flutemetamol Positron Emission Tomography (PET) Images

A Study to Evaluate the Effectiveness of an Electronic Training Program for Orienting and Interpreting [18F]Flutemetamol Positron Emission Tomography (PET) Images.

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01672827
Enrollment
276
Registered
2012-08-27
Start date
2012-07-31
Completion date
2012-08-31
Last updated
2014-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's Disease, Mild Cognitive Impairment

Keywords

Alzheimer's Disease, Mild Cognitive Impairment, Positron Emission Tomography (PET), PET Images

Brief summary

To Evaluate the Effectiveness of an Electronic Training Program for Orienting and Interpreting \[18F\]flutemetamol Positron Emission Tomography (PET) Images.

Interventions

No drug is administered in this intervention. These are scanned images being reviewed, previously acquired in various GE-067 studies.

Sponsors

GE Healthcare
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Subject received a dose of Flutemetamol F 18 Injection ranging from approximately 185 MBq to approximately 370 MBq. * The subject was classified as one of the following: 1. End-of-life subject who expired and underwent brain autopsy, with histochemical (HC) confirmation of brain amyloid status. 2. Subject with known/suspected normal pressure hydrocephalus (NPH) who underwent brain biopsy, with HC confirmation of brain amyloid status. 3. Elderly healthy volunteer (age ≥55). 4. Young healthy volunteer (age ≤40). 5. Subject with probable Alzheimer Disease (pAD). 6. Subject with amnestic Mild Cognitive Impairment (aMCI).

Exclusion criteria

* Not Applicable

Design outcomes

Primary

MeasureTime frameDescription
Summary of Sensitivity of the Blinded Visual PET Image Interpretations Without Anatomic Images.Post flutemetamol administrationStatistical analysis of summary of the blinded visual PET Image Interpretations without Anatomic Images. This data consists of image interpretations by 5 Readers and No subjects were dosed in this study. These Readers examined the PET images for evidence of amyloid plaque.
Summary of Specificity of Blinded Visual PET Image Interpretations Without Anatomic Images.Post flutemetamol administrationStatistical analysis of summary of sensitivity of blinded visual PET image interpretations without anatomic images. This data consists of image interpretations by 5 Readers and No subjects were dosed in this study.These Readers examined the PET images for evidence of amyloid plaque.

Secondary

MeasureTime frameDescription
Inter-Reader Agreement of PET Images Without Anatomic ImagesPost Flutemetamol InjectionStatistical analysis of Inter-Reader Agreement of PET Images without anatomic Images. This data consists of image interpretations by investigators and No subjects were dosed in this study.

Participant flow

Recruitment details

This study examined brain PET scans from 276 subjects previously acquired form various GE Healthcare studies (GE-067. The study did not enroll the blinded image Readers.

Participants by arm

ArmCount
[18F]Flutemetamol
No subjects were dosed for this study. Product was used in scans previously acquired in various GE-067 studies. This study was designed to evaluate the effectiveness of an electronic training program for orienting and interpreting Flutemetamol Positive Emission Tomography (PET) Images.
276
Total276

Baseline characteristics

Characteristic[18F]Flutemetamol
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
195 Participants
Age, Categorical
Between 18 and 65 years
81 Participants
Age, Continuous68.2 years
STANDARD_DEVIATION 17.1
Region of Enrollment
Belgium
66 participants
Region of Enrollment
Denmark
12 participants
Region of Enrollment
Finland
37 participants
Region of Enrollment
Japan
16 participants
Region of Enrollment
Sweden
3 participants
Region of Enrollment
United Kingdom
24 participants
Region of Enrollment
United States
118 participants
Sex: Female, Male
Female
136 Participants
Sex: Female, Male
Male
140 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 0
serious
Total, serious adverse events
0 / 0

Outcome results

Primary

Summary of Sensitivity of the Blinded Visual PET Image Interpretations Without Anatomic Images.

Statistical analysis of summary of the blinded visual PET Image Interpretations without Anatomic Images. This data consists of image interpretations by 5 Readers and No subjects were dosed in this study. These Readers examined the PET images for evidence of amyloid plaque.

Time frame: Post flutemetamol administration

Population: Number of Blinded visual PET Image Interpretations from Readers 1-5. These Readers provided their interpretations without Anatomic Images who had abnormal Standard of Truth (SoT).

ArmMeasureGroupValue (NUMBER)
Sensitivity %Summary of Sensitivity of the Blinded Visual PET Image Interpretations Without Anatomic Images.Reader 194 Percentage (True Positive)
Sensitivity %Summary of Sensitivity of the Blinded Visual PET Image Interpretations Without Anatomic Images.Reader 292 Percentage (True Positive)
Sensitivity %Summary of Sensitivity of the Blinded Visual PET Image Interpretations Without Anatomic Images.Reader 390 Percentage (True Positive)
Sensitivity %Summary of Sensitivity of the Blinded Visual PET Image Interpretations Without Anatomic Images.Reader 494 Percentage (True Positive)
Sensitivity %Summary of Sensitivity of the Blinded Visual PET Image Interpretations Without Anatomic Images.Reader 584 Percentage (True Positive)
Sensitivity %Summary of Sensitivity of the Blinded Visual PET Image Interpretations Without Anatomic Images.Majority Read94 Percentage (True Positive)
Primary

Summary of Specificity of Blinded Visual PET Image Interpretations Without Anatomic Images.

Statistical analysis of summary of sensitivity of blinded visual PET image interpretations without anatomic images. This data consists of image interpretations by 5 Readers and No subjects were dosed in this study.These Readers examined the PET images for evidence of amyloid plaque.

Time frame: Post flutemetamol administration

Population: Number of Blinded visual PET Image Interpretations from Readers 1-5. These Readers provided their interpretations without Anatomic Images who had normal Standard of Truth (SoT).

ArmMeasureGroupValue (NUMBER)
Sensitivity %Summary of Specificity of Blinded Visual PET Image Interpretations Without Anatomic Images.Reader 179 Percentage (True Negative)
Sensitivity %Summary of Specificity of Blinded Visual PET Image Interpretations Without Anatomic Images.Reader 281 Percentage (True Negative)
Sensitivity %Summary of Specificity of Blinded Visual PET Image Interpretations Without Anatomic Images.Reader 393 Percentage (True Negative)
Sensitivity %Summary of Specificity of Blinded Visual PET Image Interpretations Without Anatomic Images.Reader 477 Percentage (True Negative)
Sensitivity %Summary of Specificity of Blinded Visual PET Image Interpretations Without Anatomic Images.Reader 596 Percentage (True Negative)
Sensitivity %Summary of Specificity of Blinded Visual PET Image Interpretations Without Anatomic Images.Majority Read92 Percentage (True Negative)
Secondary

Inter-Reader Agreement of PET Images Without Anatomic Images

Statistical analysis of Inter-Reader Agreement of PET Images without anatomic Images. This data consists of image interpretations by investigators and No subjects were dosed in this study.

Time frame: Post Flutemetamol Injection

ArmMeasureGroupValue (NUMBER)
Sensitivity %Inter-Reader Agreement of PET Images Without Anatomic ImagesReader 1 vs Reader 2248 Number of inter-reader agreements
Sensitivity %Inter-Reader Agreement of PET Images Without Anatomic ImagesReader 1 vs Reader 3257 Number of inter-reader agreements
Sensitivity %Inter-Reader Agreement of PET Images Without Anatomic ImagesReader 1 vs Reader 4242 Number of inter-reader agreements
Sensitivity %Inter-Reader Agreement of PET Images Without Anatomic ImagesReader 1 vs Reader 5251 Number of inter-reader agreements
Sensitivity %Inter-Reader Agreement of PET Images Without Anatomic ImagesReader 2 vs Reader 3255 Number of inter-reader agreements
Sensitivity %Inter-Reader Agreement of PET Images Without Anatomic ImagesReader 2 vs Reader 4250 Number of inter-reader agreements
Sensitivity %Inter-Reader Agreement of PET Images Without Anatomic ImagesReader 2 vs Reader 5251 Number of inter-reader agreements
Sensitivity %Inter-Reader Agreement of PET Images Without Anatomic ImagesReader 3 vs Reader 4253 Number of inter-reader agreements
Sensitivity %Inter-Reader Agreement of PET Images Without Anatomic ImagesReader 3 vs Reader 5268 Number of inter-reader agreements
Sensitivity %Inter-Reader Agreement of PET Images Without Anatomic ImagesReader 4 vs Reader 5245 Number of inter-reader agreements
Sensitivity %Inter-Reader Agreement of PET Images Without Anatomic ImagesReaders 1,2,3,4,5223 Number of inter-reader agreements

Source: ClinicalTrials.gov · Data processed: Mar 11, 2026